RICHARD SHERIFF: Open Payments
NPI 1487204236 · CARROLLTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,900 in 83 payments from 18 companies in 2025. Trend: 2023 $1,047 · 2024 $1,923 · 2025 $2,900
Food & beverage: $2,111Travel & lodging: $789
| Company | Payments | Amount |
|---|---|---|
| Enterra Medical, Inc. | 5 | $1,175 |
| Phathom Pharmaceuticals, Inc. | 11 | $400 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $296 |
| ABBVIE INC. | 12 | $186 |
| Madrigal Pharmaceuticals | 6 | $170 |
| Regeneron Healthcare Solutions, Inc. | 4 | $108 |
| GENZYME CORPORATION | 4 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $87 |
| Ardelyx, Inc. | 4 | $76 |
| Ipsen Biopharmaceuticals, Inc | 3 | $76 |
Products named: VOQUEZNA, XIFAXAN, DUPIXENT, REZDIFFRA, IBSRELA, IQIRVO, LINZESS, ENTYVIO.
Industry payments across GA — which companies pay providers there.
